Hong Kong Exchange filings show that on September 22, 160 Health (02656) experienced a position shift, with deposited shares reaching a total market value of HK$213 million, representing 12.66% of the company. The shareholder deposited 22.17 million shares into Shenwan Hongyuan Securities (Hong Kong), increasing their stake by 6.38%.

160 Health (02656) released its interim results for 2026, reporting revenue of approximately RMB 319 million, a year-on-year increase of 9.7%. Gross profit reached RMB 85.37 million, up 33.3% year-on-year, while profit attributable to owners of the company amounted to RMB 2.14 million, reversing a prior loss. According to the announcement, the revenue growth was primarily fueled by the robust performance of its digital healthcare solutions segment. Revenue from digital healthcare solutions rose 27.6% to RMB 101 million, driven largely by the competitive edge of the 160AI Hospital product. The number of public hospitals partnering under the 160AI Hospital operations cooperation model grew rapidly, which in turn boosted the count of paying healthcare institution partners and accelerated growth in online marketing solution revenue.